Glenhill Advisors’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-277,288
Closed -$5.96M 44
2017
Q3
$5.96M Sell
277,288
-45,458
-14% -$719K 0.48% 37
2017
Q2
$3.11M Sell
322,746
-82,184
-20% -$534K 0.2% 43
2017
Q1
$2.41M Sell
404,930
-10,963
-3% -$52.7K 0.19% 39
2016
Q4
$1.64M Sell
415,893
-495,433
-54% -$3.63M 0.12% 41
2016
Q3
$9.56M Sell
911,326
-377,445
-29% -$5.42M 0.57% 32
2016
Q2
$18.8M Buy
1,288,771
+118,331
+10% +$2.02M 1.36% 23
2016
Q1
$22.5M Buy
1,170,440
+681,390
+139% +$13.8M 1.37% 23
2015
Q4
$11.8M Buy
489,050
+46,985
+11% +$1.18M 0.88% 23
2015
Q3
$10.8M Buy
442,065
+17,158
+4% +$486K 0.85% 27
2015
Q2
$9.95M Buy
+424,907
New +$9.26M 0.7% 31

Other funds holding DVAX

Glenhill Advisors's DVAX Position: Q4 2017 in Review

Glenhill Advisors sold out of Dynavax Technologies (DVAX) in Q4 2017, closing a stake of 277,288 shares — an estimated $5.96M sold.

Glenhill Advisors first reported a position in DVAX in Q2 2015 and held it in 10 quarters. The position peaked at $22.5M in Q1 2016. 140 funds tracked by Wall St. Rank hold DVAX as of Q4 2017.

  • Glenhill Advisors reported no remaining Dynavax Technologies position as of Q4 2017 after selling out during the quarter.
  • Glenhill Advisors sold 277,288 Dynavax Technologies shares in Q4 2017, an estimated $5.96M.
  • Glenhill Advisors first reported a position in Dynavax Technologies in Q2 2015 and held it in 10 quarters.
  • Glenhill Advisors's Dynavax Technologies position peaked at $22.5M in Q1 2016.
  • 140 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2017.

Based on Glenhill Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.